Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deregulation ofARID1A,CDH1,cMETandPIK3CAand target-related microRNA expression in gastric cancer

27 Jul 2015

Abstract excerpt

// Maider Ibarrola-Villava 1 , Marta J. Llorca-Cardeñosa 1 , Noelia Tarazona 1 , Cristina Mongort 2 , Tania Fleitas 1 , José Alejandro Perez-Fidalgo 1 , Susana Roselló 1 , Samuel Navarro 2 , Gloria Ribas 1 , Andrés Cervantes 1 1 Hematology and Medical Oncology Unit, Biomedical Research Institute INCLIVA, University of Valencia, 46010, Valencia, Spain 2 Department of Pathology, Biomedical Research Institute...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Cancer-related gene regulation
Share to Chromatin Remodeling and Cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26334097
DOI: 10.18632/oncotarget.4775

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deregulation ofARID1A,CDH1,cMETandPIK3CAand target-related microRNA expression in gastric cancerPMID 26334097Read ↗

Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancerSemantic proximity Read ↗

The Role of cMET in Gastric Cancer—A Review of the LiteratureSemantic proximity Read ↗

Clinical outcome and molecular landscape of patients with ARID1A-loss gastric cancer.Semantic proximity Read ↗

Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studiesSemantic proximity Read ↗

Association of genetic variants in and promoter hypermethylation of CDH1 with gastric cancer: a meta-analysis.Semantic proximity Read ↗

Impaired ARID1A expression attenuated the immune response in gastric cancer via histone acetylation.Semantic proximity Read ↗

ARID1A Mutations in Gastric Cancer: A Review with Focus on Clinicopathological Features, Molecular Background and Diagnostic InterpretationSemantic proximity Read ↗

Histone Deacetylases (HDACs) in Gastric Cancer: An Update of their Emerging Prognostic and Therapeutic RoleSemantic proximity Read ↗

Loss of ARID1A Expression is Related to Gastric Cancer Progression, Epstein-Barr Virus Infection, and Mismatch Repair DeficiencySemantic proximity Read ↗

Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.Semantic proximity Read ↗

Functional loss of ARID1A is tightly associated with high PD‐L1 expression in gastric cancerSemantic proximity Read ↗

Various ARID1A expression patterns and their clinical significance in gastric cancersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.